Biochemical measurements of bone turnover are helpful in the study of the pathophysiology
of skeletal metabolism and growth. However, interpretation of their results is difficult because …

The bone disease of preterm birth has traditionally been explained by a decrease in bone
formation from insufficient availability of calcium and phosphorus. However, there is …

Bone disease of prematurity is a complication of preterm birth. This article reviews the
aetiology, treatment and prevention of bone disease of prematurity. Provision of adequate …

Aim To evaluate bone metabolism in newborn preterm infants before and after a physical
therapy protocol. Method This randomized controlled clinical trial included 30 newborn …

Objective: To study the effect of physical therapy on bone mineralization, weight gain and
growth in preterm infants. Method: After fulfilling the inclusion criteria, preterm infants were …

Preterm birth affects about 10% of all live births with many resultant health challenges,
including metabolic bone disease of prematurity (MBDP), which is characterized by elevated …

Disorders affecting fetal growth are commonly associated with premature birth. IGFs and
their binding proteins (IGFBPs) are potent regulators of fetal growth. In vitro evidence …

Objective: To describe the effects of prolonged maternal treatment with MgSOi in infants who
were products of multiple pregnancies. Study Design: Case series of infants presenting with …

New markers have been used to monitor the changes of bone turnover occurring during
growth. Data on bone turnover rate during the perinatal period are, however, very scarce. In …

Identification of a biochemical marker of growth in low birth weight (LBW) infants would be of
benefit to rapidly assess the effects of illness and/or therapeutic intervention. The aims of the …